AlanHMarkowitzMD
Thoracic Surgery • Cleveland, OHAdult Cardiac Surgery, Cardiovascular Surgery
Fulltime University practice; Chair, Valvular Heart Dis; Chief Surg Officer Heart-Vascular Inst
Dr. Markowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-5770Fax+1 216-844-1202
Summary
- Principal investigator in 8 clinical trials regarding valvular heart disease and heart failure.
Clinical Expertise
- Tricuspid valve repair, Aortic surgery, Echocardiogram, Cardiopulmonary bypass, Coronary artery bypass grafting, Mitral valve surgery, Congenital aortic stenosis, Valvular disease, Maze surgery, Reoperative cardiac surgery, Valvular heart disease; alternative perfusion strategies; stroke avoidance; percutaneous valve implantation
Education & Training
Weatherhead School of Managementprof fellow, Hosp admn, 1993 - 1994
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Thoracic Surgery, 1976 - 1978- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 1970 - 1976
- US NavyMilitary service, Battalion physician, 1972 - 1974
Albany Medical CollegeClass of 1970
Certifications & Licensure
OH State Medical License 1974 - 2026- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Alan Markowitz Chair in Cardiac and Vascular Syrgery University Hispitals Cleveland Medical Center, 2019
- Physician of the Year University Hospitals 1866 Society, 2015
- Dolly Haugh Chair in Valvular Heart Surgery University Hospitals, 2008
- Join now to see all
Clinical Trials
- Anesthesia Charting Fidelity Study Start of enrollment: 2010 Aug 01
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsAre two really always better than one? Results, concerns and controversies in the use of bilateral internal thoracic arteries for coronary artery bypass grafting in th...Salil V. Deo, Salah E. Altarabsheh, Ishan K. Shah, Yang Hyun Cho, Michael McGraw
International Journal of Surgery. 2015-04-01 - 7 citationsImpact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacementJun Li, Sandeep M. Patel, Fahd Nadeem, Prashanth Thakker, Sadeer G. Al-Kindi
Catheterization and Cardiovascular Interventions. 2019-02-15 - 118 citationsSimultaneous Biatrial High-Density (510-512 Electrodes) Epicardial Mapping of Persistent and Long-Standing Persistent Atrial Fibrillation in Patients: New Insights Int...Seungyup Lee, Jayakumar Sahadevan, Celeen M. Khrestian, Ivan Cakulev, Alan H. Markowitz
Circulation. 2015-12-01
Press Mentions
UH Cleveland Medical Center Expanding Aortic Valve Replacement Procedure to Low-Risk PatientsDecember 19th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
